Abstract:Ferroptosis is an iron-dependent, novel form of programmed cell death characterized by lipid peroxidation and glutathione depletion and is widespread in a variety of diseases. CD8+ T cells are the most important effector cells of cytotoxic T cells, capable of specifically recognizing and killing cancer cells. Traditionally, CD8+ T cells are thought to induce cancer cell death mainly through perforin and granzyme, and Fas-L/Fas binding. In recent years, CD8+ T cell-derived IFN-γ was found to promote cancer cell ferroptosis by multiple mechanisms, including upregulation of IRF1 and IRF8, and downregulation of the system XC-, while cancer cells ferroptosis was shown to enhance the anti-tumor effects of CD8+ T cell by heating the tumor immune microenvironment through the exposure and release of tumor-associated specific antigens, which results in a positive feedback pathway. Unfortunately, the intra-tumoral CD8+ T cells are more sensitive to ferroptosis than cancer cells, which limits the application of ferroptosis inducers in cancer. In addition, CD8+ T cells are susceptible to being regulated by other immune cell ferroptosis in the TME, such as tumor-associated macrophages, dendritic cells, Treg, and bone marrow-derived immunosuppressive cells. Together, these factors build a complex network of CD8+ T cells and ferroptosis in cancer. Therefore, we aim to integrate relevant studies to reveal the potential mechanisms of crosstalk between CD8+ T cells and ferroptosis, and to summarize preclinical models in cancer therapy to find new therapeutic strategies in this review.

The crosstalk between oncogenic signaling and ferroptosis in cancer

Targeting Ferroptosis in Breast Cancer

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

The crosstalk of CD8+ T cells and ferroptosis in cancer

Crosstalk Between Ferroptosis and Stress—implications in Cancer Therapeutic Responses

Ferroptosis in cancer and cancer immunotherapy

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer

Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation

Broadening horizons: the role of ferroptosis in cancer

Advances in ferroptosis of cancer therapy

The function and mechanism of ferroptosis in cancer

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy

Ferroptosis and its emerging role in tumor

Ferroptosis as a potential target for cancer therapy

The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer

Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application